Remove Genetic Engineering Remove Genetics Remove Insulin
article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market. Novozymes has a long legacy of enzyme discovery and the ability to genetically engineer these speciality enzymes to be superior. Developing best-in-class speciality enzymes.

Drugs 295
article thumbnail

From Gene to Protein: The Journey of Protein Expression Technology

Roots Analysis

Algal Expression System: This expression system is used in genetic engineering, biofuel production, botany. Hormones (includes recombinant insulin, erythropoietin and growth hormones) Enzyme replacement therapies used in treatment of rare genetic disorders such as Gaucher disease.

Protein 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

XTalks

A growing area in the immunotherapy space is the development of biological modulators, which are genetically engineered proteins that target specific components of the immune system.

Protein 98
article thumbnail

What Are the Top 10 Diabetes Medications? A Look at Recent Sales Trends

XTalks

From blockbuster drugs like Ozempic to foundational treatments like insulin, these therapies showcase the diverse strategies used by pharma companies to meet the needs of a rapidly growing market. Price of Insulin: Varies significantly by type and brand of insulin. The company is targeting revenue of $40.4 billion to $41.6

Sales 105
article thumbnail

Key Trends in the Microbial CMO Market

Roots Analysis

Rising Demand for Biopharmaceuticals: The increasing demand for biologics including vaccines, insulin, and monoclonal antibodies, is one of the key factors driving the microbial fermentation industry. Microorganisms can be genetically engineered to produce complex biologics with high efficiency and lower costs.